OTCMKTS:CPMD

Golden Dragon Q4 2024 Earnings Report

Golden Dragon logo
$0.0024 0.00 (0.00%)
As of 06/25/2026 03:23 PM Eastern

Golden Dragon EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Golden Dragon Revenue Results

Actual Revenue
$0.48 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Golden Dragon Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Golden Dragon Earnings Headlines

Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
PSIQ Profile Solutions, Inc.
CannaPharmaRX, Inc. (CPMD)
See More Golden Dragon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Golden Dragon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Golden Dragon and other key companies, straight to your email.

About Golden Dragon

CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It evaluates, negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.

View Golden Dragon Profile